BSX

BOSTON SCIENTIFIC DL-,01 BSX

Market Open
20 Jun, 06:08
XBER XBER
71. 00
+0.5
+0.71%
0 Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
70.50
Previous Close
Day Range
71 71
Year Range
45.72 73

BSX Chart

BOSTON SCIENTIFIC DL-,01 Profile

Other Industry
Other Sector
Mr. Michael F. Mahoney CEO
XBER Exchange
- ISIN
United States Country
48,000 Employees
- Last Dividend
- Last Split
- IPO Date
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Contact Information

Address: 300 Boston Scientific Way
Phone: 508 683 4000